drugset / Trial / NCT02077868
Evaluation of MGN1703 Maintenance Treatment in Patients With mCRC With Tumor Reduction During Induction Treatment
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this this trial is to prove the efficacy and safety of MGN1703 as a maintenance therapy after first-line chemotherapeutic treatment of metastatic colorectal cancer.
Timeline
- Start
- 2014-09
- Primary completion
- 2019-02
- Completion
- 2020-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | lefitolimod | Oligonucleotide (other) | — | — |